PT  - JOURNAL ARTICLE
AU  - Panovska-Griffiths, J.
AU  - Kerr, C.C.
AU  - Waites, W.
AU  - Stuart, R.M.
AU  - Mistry, D.
AU  - Foster, D.
AU  - Klein, D.J.
AU  - Viner, R.M.
AU  - Bonell, C.
TI  - The potential contribution of face coverings to the control of SARS-CoV-2 transmission in schools and broader society in the UK: a modelling study
AID  - 10.1101/2020.09.28.20202937
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.28.20202937
4099  - http://medrxiv.org/content/early/2020/09/29/2020.09.28.20202937.short
4100  - http://medrxiv.org/content/early/2020/09/29/2020.09.28.20202937.full
AB  - Recent findings suggest that an adequate test-trace-isolate (TTI) strategy is needed to prevent a secondary COVID-19 wave with the reopening of society in the UK. Here we assess the potential importance of mandatory masks in the parts of community and in secondary schools. We show that, assuming current TTI levels, adoption of masks in secondary schools in addition to community settings can reduce the size of a second wave, but will not prevent it; more testing of symptomatic people, tracing and isolating of their contacts is also needed. To avoid a second wave, with masks mandatory in secondary schools and in certain community settings, under current tracing levels, 68% or 46% of those with symptomatic infection would need to be tested if masks’ effective coverage were 15% or 30% respectively, compared to 76% and 57% if masks are mandated in community settings but not secondary schools.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWW acknowledges the support of the Chief Scientist Office (COV/EDI/20/12).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.